stocktools
Offerings // Vor Biopharma Inc.

VOR offering history

Every offering-related filing in Vor Biopharma Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 461 filings back to Jul 10, 2020.

Last executed offering
Oct 30, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Sep 4, 2026
S-3ASR — capacity, not a sale
Executed, last 12 months
5
424B pricings + 8-K 3.02 sales
Registered, last 12 months
4
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 30, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 4, 2026S-3ASR →REGISTEREDAutomatic shelf registration — effective immediately (large filers)
May 6, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 27, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 27, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 5, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 4, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 29, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 18, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 1, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 12, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 10, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Nov 10, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 24, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Aug 27, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 26, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 31, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 20, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 29, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 21, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 27, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 23, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 14, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 8, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 7, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 18, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 14, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 8, 2021424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 5, 2021S-1MEF →REGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Feb 4, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 3, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 3, 2021FWP →MARKETINGFree-writing prospectus — offering being marketed
Feb 1, 2021S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 15, 2021S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
VOR offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full VOR workspace →
VOR offering FAQ

When did VOR last execute an offering?

Per SEC filings, Vor Biopharma Inc.'s most recent priced offering document is a 424B5 filed 2026-10-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did VOR last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-09-04. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.